This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Csl Behring Ag. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Bo An - Innovator in Hemopexin Formulations
Introduction
Bo An is a notable inventor based in Bourbonnais, IL (US). He has made significant contributions to the field of biochemistry, particularly through his innovative work on hemopexin formulations. His research focuses on creating stable liquid formulations that can have various applications in medical science.
Latest Patents
Bo An holds a patent for a formulation of purified hemopexin. This invention includes a stable liquid formulation comprising: (a) a hemopexin content of at least 50 mg/mL; (b) at least 15 mM phosphate buffer; (c) a pH from 5.8 to 8; and (d) at least 50 mM sodium chloride. This formulation has potential uses in therapeutic applications, showcasing the importance of his work in the medical field.
Career Highlights
Bo An is currently associated with CSL Behring AG, a company known for its focus on biopharmaceuticals. His role at the company allows him to further his research and development efforts in the area of hemopexin and its applications.
Collaborations
Throughout his career, Bo An has collaborated with notable colleagues such as Thomas Gentinetta and Nathan Brinkman. These collaborations have likely contributed to the advancement of his research and the successful development of his patent.
Conclusion
Bo An is a dedicated inventor whose work on hemopexin formulations has the potential to impact the medical field significantly. His contributions, along with his collaborations, highlight the importance of innovation in biochemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile